header
February 12, 2021

In This Issue
MMA Weekly State Vaccination Plan Update
MMA Leadership & Staff Share Condolences on Passing of George Smith
Maine PMP to Stay with Appriss System
Next Maine CDC COVID-19 Update for Clinicians with Stephen Sears, MD scheduled for Feb 25
Federal Government Finalizes Purchase of 200M COVID-19 Vaccines Doses
US CDC: Fully Vaccinated Meeting Criteria No Longer Required to Quarantine After Exposure
AMA President: Physicians & Medical Societies Can Play Vital Role Advocating for Strong Public Health
NEJM: The FDA’s Experience with Covid-19 Antibody Tests
NEJM: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Monoclonal Antibody Authorization from the FDA (Updated 02/09/21) & MaineCare Reimbursement
Guidance for Industry: Investigational COVID-19 Convalescent Plasma (Updated 02/11/20)
Maine Legislative Leadership COVID-19 Bill Set for Public Hearing Tuesday
Next MMA Legislative Call Will Be Wednesday, February 17th
Daniel Hanley Center for Health Leadership’s Renowned Physician Executive Leadership Institute – The Advanced Course Enrollment is OPEN
PPE Available Through the MMA & ActionPPE
A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
Maine Legislature Week 5 Update
Upcoming Public Hearings & Work Sessions; New Bills Introduced
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
Suicide Prevention and Management in Healthcare Practice Settings: A Comprehensive Evidence-Based Approach
MOA VIRTUAL Midwinter Symposium - February 12th-14th
Maine CDC Annual Prevention Professionals Conference - March 2nd-3rd
AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Physician (BC/BE in Family Medicine)
Nursing Director
Medical Director - Bucksport Regional Health Center
Rangeley Family Medicine seeks Physician

 
Search Back Issues



 

 

 


Follow Us:
NEJM: The FDA’s Experience with Covid-19 Antibody Tests

Jeffrey Shuren, M.D., J.D., and Timothy Stenzel, M.D., Ph.D. from the Food and Drug Administration (FDA) review the process, procedures, and challenges related to evaluating test performance and authorizing products—specifically antibody tests—early in the pandemic. Their conclusion: “Moving forward, the FDA will continue to take steps to ensure the timely availability of accurate and reliable antibody tests to meet the public health need as the pandemic evolves.” 

Read the article. 

Author’s Conclusions: 

First, our experience with serology tests underscores the importance of authorizing medical products independently, on the basis of sound science, and not permitting market entry of tests without authorization. 

Second, the federal government should coordinate the preparation of a public–private research plan to address epidemiologic questions regarding disease spread and immunity at the beginning of an outbreak as part of its preparedness plan. 

Third, we should establish the capacity within or on behalf of the federal government to evaluate test performance before outbreaks occur so that independent evaluation can be performed quickly during an outbreak. 

Fourth, the scientific and medical communities should understand the purpose and clinical use of serology tests and how to appropriately use test results in general to inform patient care. 

Finally, all parties involved in public health emergency response need better information more quickly.

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©